Skip to content
value.today
T2 Biosystems, Inc. logo

T2 Biosystems, Inc.

TTOO
$25 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$18 M
Dec-2020 ending year
value.today research
Net income
$-47 M
-258.0% margin
value.today research
Employees
—

T2 Biosystems, Inc. in brief

T2 Biosystems, Inc. is a listed company in the Diagnostics and Research industry, based in Massachusetts, USA. It was founded in 2006. Its last known market value was $25 M (January 2024); there is no current figure. In the year to Dec 2020 it had sales of $18 M and a net loss of $47 M. Its shares trade under the symbol TTOO (Frankfurt).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

T2 Biosystems, Inc. timeline

2 events, 2006–2014
  1. 2006
  2. 🏁
    · approximate
    Founded
  3. 2014
  4. 🔔
    · approximate
    Initial public offering on Frankfurt

Events of T2 Biosystems, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$50 M$99 M$149 M$199 M20202021202220232024

World rank over time

▼ down 6,393 places since 2020
2020-01-01: #21645#21,64520202021-01-01: #15863#15,86320212022-01-07: #23877#23,87720222022-12-25: #31857#31,85720222023-07-30: #33627#33,62720232024-01-05: #28038#28,0382024

Rank in USA: #4,076 (Jan 2020) · #3,296 (Jan 2021) · #4,600 (Jan 2022) · #5,636 (Dec 2022) · #5,700 (Jul 2023) · #4,305 (Jan 2024)

Annual results

Revenue
$18 M
Operating income
—
Net income
$-47 M

Dec-2020 ending year

Lobbying by T2 Biosystems, Inc.#

$0 spent on lobbying the US Congress and federal agencies in 2025, most often on health issues.

Lobbying, 2025
$0
#1,549 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2025
2026 so far
—
  • Health Issues1 report

Lobbying firms hired in 2025

FOLEY HOAG LLP

T2 Biosystems, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2025$0—1
2024$0—4
2023$23 K—4
2022$19 K—2

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “T2 Biosystems”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at T2 Biosystems, Inc.#

1 labor condition applications certified in fiscal 2023 for 1 positions, at a median wage of $75 K a year.

Certified, FY2023
1
#2,026 among companies on value.today
Worker positions
1
Median wage offered
$75 K
a year, full-time
Applications filed
1
T2 Biosystems, Inc.: most frequent H-1B job titles in fiscal 2023
Job titlePositionsMedian wage offered
QA Documentation Specialist [00051910]Regulatory Affairs Specialists1$75 K

Where: Lexington, MA 1

T2 Biosystems, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202311$75 K1
FY202211$68 K1
FY202011$104 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as T2 Biosystems, Inc.

Product recalls by T2 Biosystems, Inc.#

1 recalls since 2015, 6,864 units in the notices that give a number. Medical devices (FDA): 1.

T2 Biosystems, Inc.: product recalls
DateWhat and whyUnitsNotice
T2Candida¿Cartridges; Part Number: 90-01794 (box of 12) and Part Number: 91-01534 (individual cartridge base). A qualitative T2 Magnetic Resonance (T2MR¿) assay for the direct detection of Candida species in EDTA human whole blood specimens.Elevated levels of invalid results.Medical devicesClass II6,864Z-2795-2016

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

How T2 Biosystems, Inc. compares in Diagnostics and Research

  • Revenue$18 M · higher than 19% of 123
  • Net margin-258.0% · higher than 5% of 112

Peer comparison · Diagnostics and Research

CompanyMarket capP/ENet marginRev. growth
T2 Biosystems, Inc.🇺🇸$25 M—-258.0%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%
Danaher Corporation🇺🇸$166.7 B38.5×16.9%+2.9%
WuXi AppTec Co., Ltd.🇨🇳$70.4 B25.4×42.1%—
Natera, Inc.🇺🇸$58.7 B—-5.7%+35.9%
Siemens Healthineers AG🇩🇪$52.8 B22.9×8.7%—
Lonza Group AG🇨🇭$51.9 B—-4.2%—
Agilent Technologies, Inc.🇺🇸$48.8 B33.9×19.5%+6.7%
IQVIA Holdings Inc.🇺🇸$45.1 B32.4×8.1%+5.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2020 ending year
Balance sheet:
Dec-2020 ending year
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at T2 Biosystems, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show T2 Biosystems, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about T2 Biosystems, Inc.? Suggest a correction